| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |